NCT05014438 A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT05005273 A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT05002569 A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma Status TERMINATED Phase PHASE3
NCT04989946 Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04987203 Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma Status COMPLETED Phase PHASE3
NCT04984733 Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer Status COMPLETED Phase PHASE2
NCT04969887 Combination Immunotherapy in Rare Cancers Under InvesTigation Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04965402 A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986166 in Healthy Japanese Participants Status COMPLETED Phase PHASE1
NCT04965389 A Study of Milvexian Using an IV Microtracer With Additional Formulation and Food Effect Comparison in Healthy Participants Status COMPLETED Phase PHASE1
NCT04963283 Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04956627 A Study to Assess the Effect of Itraconazole, Phenytoin and Gemfibrozil on the Drug Levels of BMS-986166 in Healthy Participants Status COMPLETED Phase PHASE1
NCT04949269 A Study to Evaluate the Drug Levels of Deucravacitinib From Tablets After Oral Administration in Healthy Participants Status COMPLETED Phase PHASE1
NCT04949113 Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04943900 A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors Status COMPLETED Phase PHASE1
NCT04941755 A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy Participants Status COMPLETED Phase PHASE1
NCT04938232 Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL Status ACTIVE_NOT_RECRUITING Phase PHASE2